Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-113827
Filing Date
2025-09-09
Accepted
2025-09-09 17:03:18
Documents
3
Period of Report
2025-09-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A sept._2025_special_meet_.htm PRE 14A 185629
2 GRAPHIC img150613947_0.jpg GRAPHIC 77240
3 GRAPHIC img150613947_1.jpg GRAPHIC 60728
  Complete submission text file 0000950170-25-113827.txt   377169
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33221 | Film No.: 251303958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)